United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Oct 1, 2026 · Filed Oct 2, 2026

On Oct 1, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$576.47 for US$5.48M under a trading plan, leaving 324,443 shares. Filed Oct 2, 2026 (Form 4).

Sold
9,500 shares
Price
US$576.47 average (US$560.05 to US$584.66)
Value
US$5.48M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 1, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Oct 1, 2026Common StockSale120US$560.05333,823Indirect
Oct 1, 2026Common StockSale80US$561.68333,743Indirect
Oct 1, 2026Common StockSale160US$563.31333,583Indirect
Oct 1, 2026Common StockSale94US$567.90333,489Indirect
Oct 1, 2026Common StockSale306US$569.65333,183Indirect
Oct 1, 2026Common StockSale534US$570.55332,649Indirect
Oct 1, 2026Common StockSale320US$571.52332,329Indirect
Oct 1, 2026Common StockSale560US$572.86331,769Indirect
Oct 1, 2026Common StockSale280US$573.62331,489Indirect
Oct 1, 2026Common StockSale830US$574.94330,659Indirect
Oct 1, 2026Common StockSale1,346US$575.90329,313Indirect
Oct 1, 2026Common StockSale774US$576.91328,539Indirect
Oct 1, 2026Common StockSale930US$577.93327,609Indirect
Oct 1, 2026Common StockSale320US$579.02327,289Indirect
Oct 1, 2026Common StockSale864US$580.20326,425Indirect
Oct 1, 2026Common StockSale702US$581.21325,723Indirect
Oct 1, 2026Common StockSale520US$582.24325,203Indirect
Oct 1, 2026Common StockSale400US$583.28324,803Indirect
Oct 1, 2026Common StockSale360US$584.66324,443Indirect

Source

View original at SEC

Related